You have been diagnosed with kidney cancer type clear cell.
Kidney stem cell clinical trials.
The harvard stem cell institute hsci kidney group has short medium and long term strategies to develop new therapies for diabetes related kidney damage diabetic nephropathy.
Clinical trial of mesenchymal stem cells in the treatment of severe acute kidney injury wed 12 11 2019 12 00 conditions.
Study related tests procedures and medications are provided at no cost.
Harvard university dedicates program specifically to kidney stem cell research for ckd and dialysis patients.
Find open clinical trials related to regenerative medicine therapy.
Find clinical trials to treat kidney cancer.
Hickson is part of the research team looking at using stem cells to help regenerate failing kidneys.
You may be eligible if.
Diabetic kidney disease also known as diabetic nephropathy is the most common cause of chronic kidney disease and end stage kidney failure requiring dialysis or kidney transplantation.
There are currently no fda approved treatments for kidney disease that use stem cells but researchers are conducting clinical trials to test whether stem cell based therapies for kidney diseases are safe and effective in humans.
Learn about volunteering in a clinical trial.
This phase iii trial compares nephrectomy surgery to remove a kidney or part of a kidney with nivolumab to the usual approach of nephrectomy followed by standard post operative follow up and monitoring in treating patients with kidney cancer that is limited to a certain part of the body localized.
Clinical trials are ongoing however with the goal of testing whether such therapies are effective and safe in humans.
New therapies are being developed by the harvard stem cell institute to repair kidney damage and reduce the need for transplantation.
Regenerative cell based therapy applying mscs holds promise to delay the progression of kidney disease in individuals with diabetes mellitus.
Click here for their list of clinical trials which are currently.
The website clinicaltrials gov has the most up to date information about the status of these trials.
This multi pronged approach aims to capitalize on promising translational achievements in the near future while pursing potential drugs and the ultimate goal of.
You are 18 or older.
Currently there are no stem cell treatments for kidney disease that are approved by the fda.
Our goal is to take a look at how we can repair the diabetic kidney in terms of delaying the rate of progression of kidney failure says latonya hickson m d a mayo clinic nephrologist.
You can browse trials categorized by disease or condition or by procedure or can use specific search terms and filter results by location study status gender study phase and more.